We then analyzed the effect of Nutlin-3a treatment on the viability of primary Ph+ and Ph− ALL cells carrying wild-type p53, by incubating cells with 5 μM Nutlin-3a for 24 hours. This evidence concerns the gene TP53 and acute lymphoblastic leukemia.